Year archive

PHARMANIAGA BERHAD — 2026 filings

All 29 regulatory filings released by PHARMANIAGA BERHAD in 2026, sourced directly from the official regulator.

29 Filings

2026 Period

2026 filings (29)

Filing	Released	Lang
PHARMA - Notice of Book Closure Share Issue/Capital Change	2026-05-20	English
Share Consolidation Share Issue/Capital Change	2026-05-19	English
General Meetings: Outcome of Meeting Declaration of Voting Results & Voting Rights Announcements	2026-05-18	English
General Meetings: Outcome of Meeting Declaration of Voting Results & Voting Rights Announcements	2026-05-18	English
PHARMA - Notice of Book Closure Notice of Dividend Amount	2026-05-18	English
Interim Dividend Notice of Dividend Amount	2026-05-17	English
Quarterly rpt on consolidated results for the financial period ended 31/03/2026 Interim / Quarterly Report Q1 2026	2026-05-17	English
CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA SHARE(S)") INTO 1 PHARMANIAGA SHARE HELD ON AN ENTITLEMENT DA Regulatory Filings	2026-04-26	English
General Meetings: Notice of Meeting Regulatory Filings	2026-04-23	English
Annual Report & CG Report - 2025 Regulatory Filings	2026-04-16	English
CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE Regulatory Filings	2026-04-16	English
General Meetings: Notice of Meeting Regulatory Filings	2026-04-15	English
SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIA Regulatory Filings	2026-04-13	English
SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIA Regulatory Filings	2026-04-07	English
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONSPHARMANIAGA BERHAD ("PB" OR "THE COMPANY") CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHA Regulatory Filings	2026-04-07	English
SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIA Regulatory Filings	2026-04-06	English
Annual Audited Accounts - 31 Dec 2025 Regulatory Filings	2026-04-01	English
Changes in Director's Interest (Section 219 of CA 2016) - DATO’ SERI DR HJ AWALUDIN BIN SAID Regulatory Filings	2026-03-26	English
PHARMANIAGA BERHAD - UPLIFTMENT OF PN17 STATUS Regulatory Filings	2026-03-15	English
PHARMANIAGA BERHAD - UPLIFTMENT OF PN17 STATUS Regulatory Filings	2026-03-15	English
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN Regulatory Filings	2026-03-15	English
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period Regulatory Filings	2026-03-12	English
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT Regulatory Filings	2026-03-01	English
Quarterly rpt on consolidated results for the financial period ended 31/12/2025 Regulatory Filings	2026-02-22	English
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT Regulatory Filings	2026-02-02	English
Change in Audit Committee - DATUK MOHD ADZAHAR BIN ABDUL WAHID Regulatory Filings	2026-01-22	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD Regulatory Filings	2026-01-05	English
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - JAKEL MEDICAL SDN BHD Regulatory Filings	2026-01-04	English
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT Regulatory Filings	2026-01-01	English